Aditxt, Inc. (ADTX) Financial Ratios
9 years of historical data (2017–2025) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
0.00
↓-100% vs avg
5yr avg: 1054967.53
30Y Low1.7·High1.7
ROE
↓
-681.6%
↑-65% vs avg
5yr avg: -413.3%
30Y Low-438%·High-224%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
ADTX Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $335 | $7M | $13.2B | — | — | — | — | — | — | — |
| Enterprise Value | $6M | $13M | $13.2B | — | — | — | — | — | — | — |
| P/E Ratio → | 0.00 | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 0.10 | 2108.72 | 98346.73 | — | — | — | — | — | — | — |
| P/B Ratio | 0.00 | 1.70 | 1590.20 | 82192.04 | 826971.03 | 4364082.69 | 1178195.12 | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
ADTX EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4013.99 | 98392.16 | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — |
ADTX Profitability
Margins and return-on-capital ratios measuring operating efficiency
Aditxt, Inc. earns an operating margin of -612542.2%. Operating margins have compressed from -4039.6% to -612542.2% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -681.6% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 8.4% | 8.4% | -368.0% | -17.3% | 17.9% | 25.8% | — | — | — | — |
| Operating Margin | -612542.2% | -612542.2% | -20796.4% | -4039.6% | -2728.9% | -39925.2% | — | — | — | — |
| Net Profit Margin | -1305608.8% | -1305608.8% | -25708.8% | -5018.9% | -2961.3% | -44148.6% | — | — | — | — |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -681.6% | -681.6% | -283.1% | -304.7% | -359.4% | -437.6% | -224.3% | — | — | — |
| ROA | -171.4% | -171.4% | -89.8% | -117.1% | -201.8% | -311.6% | -138.4% | -4873.5% | -8086.2% | -852.0% |
| ROIC | -120.2% | -120.2% | -86.1% | -97.8% | -297.4% | -670.8% | — | — | — | — |
| ROCE | -300.3% | -300.3% | -203.2% | -202.2% | -252.9% | -336.5% | -196.8% | — | — | — |
ADTX Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $6M ($7M total debt minus $833031 cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.75 | 1.75 | 0.84 | 1.14 | 0.65 | 0.46 | 0.17 | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 1.54 | 0.73 | 1.13 | 0.12 | -0.31 | -0.79 | — | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | -0.04 |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -16.92 | -16.92 | -3.76 | -4.07 | -11.10 | -22.92 | -28.51 | -3018.55 | -70.32 | — |
ADTX Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.31x is below 1.0, meaning current liabilities exceed current assets. The quick ratio of -0.16x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.31 | 0.31 | 0.09 | 0.27 | 1.30 | 2.61 | 8.99 | 0.00 | 0.07 | 0.42 |
| Quick Ratio | -0.16 | -0.16 | 0.08 | 0.24 | 1.04 | 2.47 | 8.99 | 0.00 | 0.07 | 0.42 |
| Cash Ratio | 0.07 | 0.07 | 35.59 | 0.00 | 0.76 | 2.18 | 8.56 | 0.00 | 0.07 | 0.42 |
| Asset Turnover | — | 0.00 | 0.00 | 0.01 | 0.09 | 0.01 | — | — | — | — |
| Inventory Turnover | 0.00 | 0.00 | 55.80 | 1.02 | 0.81 | 0.16 | — | — | — | — |
| Days Sales Outstanding | — | — | 3138.77 | 3311.23 | 206.39 | 2049.75 | — | — | — | — |
ADTX Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Aditxt, Inc. returns 100.0% to shareholders annually primarily through share buybacks.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 100.0% | 100.0% | 0.0% | — | — | — | — | — | — | — |
| Total Shareholder Yield | 100.0% | 100.0% | 0.0% | — | — | — | — | — | — | — |
| Shares Outstanding | — | $37355 | $13177 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Peer Comparison
Compare ADTX with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 ADTXYou | $335 | 0.0 | — | — | 8.4% | -612542.2% | -681.6% | -120.2% | — |
 IMMP | $55M | -1.3 | — | — | -1117.6% | -2506.5% | -36.9% | -176.9% | — |
 CRIS | $82M | -0.7 | — | — | 99.5% | -348.4% | -138.8% | — | — |
 AGEN | $125M | -882.4 | — | — | 29.6% | -18.0% | — | — | — |
 NKTR | $1B | -6.3 | — | — | 100.0% | -236.8% | -217.9% | -57.2% | — |
 AIMD | $9M | -0.6 | — | — | -3767.2% | -11268.3% | -128.0% | -50.2% | — |
 FATE | $244M | -1.8 | — | — | -94.1% | -2222.4% | -51.8% | -36.5% | — |
 RCUS | $2B | -7.4 | — | — | 96.0% | -156.3% | -63.3% | -64.1% | — |
 IMVT | $7B | -12.8 | — | — | — | — | -64.8% | — | — |
 CABA | $463M | -1.7 | — | — | — | — | -127.0% | -429.6% | — |
 TMO | $173B | 26.2 | 18.7 | 27.4 | 37.7% | 18.2% | 13.1% | 7.5% | 3.8 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 9 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
ADTX — Frequently Asked Questions
Quick answers to the most common questions about buying ADTX stock.
What is Aditxt, Inc.'s P/E ratio?
Aditxt, Inc.'s current P/E ratio is 0.0x.
What is Aditxt, Inc.'s ROE?
Aditxt, Inc.'s return on equity (ROE) is -681.6%. The historical average is -321.8%.
Is ADTX stock overvalued?
Based on historical data, Aditxt, Inc. is trading at valuation metrics that vary. Compare with industry peers and growth rates for a complete picture.
What are Aditxt, Inc.'s profit margins?
Aditxt, Inc. has 8.4% gross margin and -612542.2% operating margin.